PHIM Responsive Header

Category: Latest News and Events

  • IDSR Epidemiological Bulletin – Week 42.

    IDSR Epidemiological Bulletin – Week 42.

    IDSR Bulletin Dashboard – Week 42, 2026

    Weekly IDSR Bulletin

    Epidemiological Week 42 (12th – 18th October, 2026)

    Status: Official Release Reporting Rate: 94% Completeness Published: 25th October 2026

    Editorial Team & Contributors

    Dr. Matthew Kagoli
    Mrs. Flora Dimba
    Austin Zgambo
    Noel Khunga
    James Jere
    Sikhona Chipeta
    Deborah Msaka
    Lameck Mughogho
    MALARIA CASES
    24,027
    2 Severe Fatalities
    COMPLETENESS
    94.0%
    Target ≥ 80% (Stable)
    TIMELINESS
    93.0%
    Target ≥ 80% (Stable)
    BLOODY DIARRHOEA
    974
    0 Deaths
    MEASLES ALERTS
    34
    34 Epi-Linked Cases
    EBS SIGNALS
    50
    29 Verified Events

    I. Main Epidemiological Feature: Disease & Event Burden in Epi Week 42

    National Feature Epi Week 42 Summary

    Malaria Reaches 24,027 Cases with 2 Deaths as EBS Signals Rise to 50

    In Epidemiological Week 42, Malaria generated 24,027 cases nationwide alongside 2 fatalities. Public health surveillance also logged 34 new Measles alerts, 974 cases of bloody diarrhoea, 100 SARI cases, 64 Typhoid cases, 56 AEFI cases, 9 Maternal deaths, 6 Meningococcal meningitis cases, and 1 Neonatal tetanus case.

    • Malaria Burden: Total reported cases expanded to 24,027 with clinical outcomes resulting in 2 fatalities in Likoma and Balaka.
    • Measles & Vaccine-Preventable Diseases: 34 new alerts/epi-linked cases reported in W42. Nsanje has accumulated 523 cumulative cases and Balaka 494 cases since early 2026.
    • Respiratory & Diarrhoeal Conditions: Severe Acute Respiratory Infections recorded 100 cases (0 deaths), while Diarrhoea with blood recorded 974 cases (0 deaths).
    Strategic Action Directives

    Case Management & Triage: Health facilities must reinforce early severe malaria clinical protocols and ensure continuous supply of mRDTs, parenteral Artesunate, and ACTs.

    Immunization Coverage: EPI teams must target persistent localized measles transmission pockets in Nsanje, Balaka, Dedza, and Chikwawa districts.

    Priority Disease & Condition Alerts (Epi Week 42)

    Distribution of reported priority conditions and outpatient/inpatient alerts nationwide

    Highest Alert Volume Bloody Diarrhoea (974)
    Vaccine Alerts AEFI (56) / Measles (34)
    Severe Fatalities Maternal (9) / Malaria (2)

    II. Health System Reporting Performance

    1. National Reporting Trend (W28 – W42)

    Analysis & Insights

    Analytics: National IDSR reporting recorded a slight decrease in Epidemiological Week 42, with completeness dropping from 95% to 94% and timeliness decreasing from 95% to 93% on the One Health Surveillance Platform (OHSP).

    Insights: Despite minor fluctuations, both metrics remain significantly above the minimum national benchmark of 80%, demonstrating sustained resilience in weekly data collection.

    Recommendations: Active supervisory tracking and system support must be maintained across all DHOs to prevent further dips and maintain target compliance.

    2. Zonal Reporting Rates (Week 42)

    Analysis & Insights

    Analytics: All health zones and Central Hospitals met or exceeded the 80% national reporting threshold. Central Hospitals and South West achieved 100% completeness and timeliness. South East logged 98% completeness and 100% timeliness, Central East scored 95% completeness and 100% timeliness, Central West achieved 91% completeness and 100% timeliness, while North achieved 82% completeness and 100% timeliness.

    Insights: Timeliness reached 100% across all health zones and referral central hospitals during Week 42.

    Recommendations: Focus support on Northern Zone DHOs to elevate completeness closer to the 95%+ standard achieved by neighboring zones.

    III. Event-Based Surveillance (EBS)

    3. Community EBS Signal Verification Status

    Analysis & Insights

    Analytics: During Epidemiological Week 42, a total of 50 EBS signals were submitted from 10 reporting districts. Verification efforts confirmed 29 signals (58%) as true public health events, while 20 signals (40%) were unverified and 1 signal (2%) was discarded.

    Insights: Signals concerning children with sudden limb weakness or fever and skin rash accounted for 18 of the 50 community signals (9 confirmed as events), indicating high alert levels for vaccine-preventable diseases.

    Recommendations: District Rapid Response Teams (DRRTs) must prioritize rapid field investigations and documented risk management plans for all verified events.

    4. Verified EBS Signals by Risk Level

    Analysis & Insights

    Analytics: Comprehensive risk assessments were conducted for all 29 verified community events. Results show 5 events (17%) categorized as Very High Risk, 5 (17%) as High Risk, 8 (28%) as Moderate Risk, and 11 (38%) as Low Risk.

    Insights: Over one-third (34%) of verified community events present High or Very High public health risk, requiring immediate response protocols.

    Recommendations: Ensure rapid DRRT deployment to the 10 High and Very High risk event locations to mitigate community transmission risks.

    IV. Epidemic Prone & Priority Conditions Performance

    5. Measles Outbreak: Cumulative Cases in Key Hotspots

    Analysis & Insights

    Analytics: In Epidemiological Week 42, 34 new epi-linked cases were recorded. Cumulative outbreak totals since early 2026 stand at Nsanje with 523 cases (84 lab-confirmed), Balaka with 494 cases (74 lab-confirmed), Chikwawa with 387 cases (38 lab-confirmed), and Dedza with 375 cases (13 lab-confirmed).

    Insights: Localized measles transmission continues in catchment areas like Golomoti (Dedza), Ngabu (Chikwawa), and Ndamera (Nsanje), whereas outbreaks in several Balaka and Machinga health facilities have been contained.

    Recommendations: Intensify routine childhood immunization coverage and supplementary immunization campaigns targeting susceptible children under 15 years.

    6. Reporting Performance by Site (Underperforming Units)

    Analysis & Insights

    Analytics: Out of 33 reporting sites, 30 (90%) achieved the national target of ≥80% for both completeness and timeliness. Three DHOs failed to meet target benchmarks: Machinga DHO and Karonga DHO failed timeliness targets, while Balaka DHO failed on both completeness (78%) and timeliness (78%).

    Insights: Dowa DHO successfully recovered performance above the 80% threshold in Week 42, leaving Machinga, Karonga, and Balaka as key priority intervention sites.

    Recommendations: Zonal epidemiology focal persons should directly assist Balaka, Karonga, and Machinga DHOs to resolve electronic reporting delays on OHSP.

    V. Targeted District & Programmatic Recommendations

    1. District Reporting Compliance

    Karonga, Balaka, and Machinga DHOs must urgently streamline data upload workflows to ensure weekly completeness and timeliness return to the ≥80% national benchmark on OHSP.

    2. Severe Malaria Management

    All District Health Offices must enforce strict clinical triage and severe malaria management to prevent fatalities and maintain stock security for mRDTs, parenteral Artesunate, and ACTs.

    3. Outbreak Surveillance & EPI Response

    DRRTs and EPI must conduct immediate risk assessments for verified community signals and strengthen routine immunization and outreach strategies to halt localized measles transmission.

    Official IDSR Documentation

    Access the full official PDF bulletin for Epidemiological Week 42, 2026, including detailed district-level performance tables and annexes.

    PUBLISHED BY

    Moses Nyambalo Phiri

    Ministry of Health, Lilongwe, Malawi

  • IDSR Epidemiological Bulletin – Week 41.

    IDSR Epidemiological Bulletin – Week 41.

    IDSR Bulletin Dashboard – Week 41, 2026

    Weekly IDSR Bulletin

    Epidemiological Week 41 (5th – 11th October, 2026)

    Status: Official Release Reporting Rate: 95% Maintained Published: 18th October 2026

    Editorial Team & Contributors

    Dr. Matthew Kagoli
    Mrs. Flora Dimba
    Austin Zgambo
    Noel Khunga
    James Jere
    Sikhona Chipeta
    Lusungu Banda
    Vincent Kamforzi
    MALARIA CASES
    19,823
    12 Inpatient Fatalities
    COMPLETENESS
    95.0%
    Target ≥ 80% (Stable)
    TIMELINESS
    95.0%
    Target ≥ 80% (Stable)
    BLOODY DIARRHOEA
    740
    0 Deaths
    MEASLES ALERTS
    53
    13 Epi-Linked Cases
    EBS SIGNALS
    30
    14 Verified Events

    I. Main Epidemiological Feature: Disease & Event Burden in Epi Week 41

    National Feature Epi Week 41 Summary

    Malaria Reaches 19,823 Cases with 12 Deaths as Measles Alerts Rise to 53

    In Epidemiological Week 41, Malaria generated 19,823 cases nationwide alongside 12 fatalities. Public health surveillance also logged 53 new Measles alerts, 740 cases of bloody diarrhoea, 84 AEFI cases, 80 Typhoid cases, 77 SARI cases (2 deaths), 8 Meningococcal meningitis cases, 6 Maternal deaths, and 2 AFP cases.

    • Malaria Burden: Total reported cases increased slightly to 19,823 with severe malaria clinical outcomes resulting in 12 inpatient fatalities.
    • Measles & Vaccine-Preventable Diseases: 53 new alerts reported in W41 with 13 epi-linked cases. Nsanje has accumulated 523 cumulative cases and Balaka 494 cases since January 2026.
    • Respiratory & Meningeal Conditions: Severe Acute Respiratory Infections recorded 77 cases with 2 deaths, while Meningococcal meningitis recorded 8 cases with 0 deaths.
    Strategic Action Directives

    Case Management & Triage: Health facilities must reinforce early severe malaria clinical protocols and ensure continuous supply of mRDTs, parenteral Artesunate, and ACTs.

    Immunization Coverage: EPI teams must target persistent localized measles transmission pockets in Nsanje, Balaka, and neighboring outbreak districts.

    Priority Disease & Condition Alerts (Epi Week 41)

    Distribution of reported priority conditions and outpatient/inpatient alerts nationwide

    Highest Alert Volume Bloody Diarrhoea (740)
    Vaccine Alerts AEFI (84) / Measles (53)
    Severe Fatalities Malaria (12) / SARI (2) / Maternal (6)

    II. Health System Reporting Performance

    1. National Reporting Trend (W28 – W41)

    Analysis & Insights

    Analytics: National IDSR reporting maintained its strong performance trajectory in Week 41, holding steady at 95% for both completeness and timeliness on the One Health Surveillance Platform (OHSP).

    Insights: Following the temporary drop to 90% in Week 39, the prompt recovery to 95% in Week 40 was successfully sustained into Week 41, reflecting effective supervisory tracking across reporting units.

    Recommendations: Maintain active routine monitoring and system support on OHSP to sustain performance above the 80% national threshold.

    2. Zonal Reporting Rates (Week 41)

    Analysis & Insights

    Analytics: All health zones and Central Hospitals met or exceeded the 80% national reporting threshold. Central Hospitals and South West achieved 100% completeness and timeliness. South East scored 97% completeness and 97% timeliness, Central East and North achieved 95% on both, and Central West logged 95% completeness and 92% timeliness.

    Insights: Central Hospitals maintained their full performance rebound at 100%, proving that reporting bottlenecks at referral level remain resolved.

    Recommendations: Continue providing support to Central West zone to lift timeliness closer to the 95%+ standard of other zones.

    III. Event-Based Surveillance (EBS)

    3. Community EBS Signal Verification Status

    Analysis & Insights

    Analytics: During Epidemiological Week 41, 30 EBS signals were submitted from 8 reporting districts. Verification efforts by District Rapid Response Teams (DRRTs) confirmed 14 signals (46.7%) as true public health events, while 16 signals (53.3%) were unverified.

    Insights: Signals involving children with sudden limb weakness (AFP) or fever and skin rash accounted for 17 of the 30 reported community signals (8 verified, 9 unverified), reflecting high community vigilance for polio and measles.

    Recommendations: DRRTs should ensure all verified community events receive rapid field investigations and documented risk management plans.

    4. Verified EBS Signals by Risk Level

    Analysis & Insights

    Analytics: Risk assessments were conducted for all 14 verified community events. Results show 5 events (36%) classified as High Risk, 3 (21%) as Moderate Risk, and 6 (43%) as Low Risk.

    Insights: With over a third (36%) of confirmed community events assessed as High Risk, active field deployment remains necessary to manage localized health hazards.

    Recommendations: Prioritize immediate DRRT deployment to the 5 high-risk event sites while establishing routine monitoring for moderate and low risk alerts.

    IV. Epidemic Prone & Priority Conditions Performance

    5. Measles Outbreak: Cumulative Cases in Key Hotspots

    Analysis & Insights

    Analytics: In Epidemiological Week 41, 13 new epi-linked cases were recorded. Cumulative outbreak totals show Nsanje with 523 cases (84 lab-confirmed) and Balaka with 494 cases (74 lab-confirmed) since January 1, 2026.

    Insights: Sporadic measles transmission persists across localized districts including Nsanje, Balaka, Dedza, Chikwawa, Mchinji, Machinga, Zomba, and Mulanje.

    Recommendations: EPI teams must maintain targeted supplementary immunization activities in affected catchments to prevent wider pediatric transmission.

    6. Reporting Performance by Site (Underperforming Units)

    Analysis & Insights

    Analytics: Out of 33 reporting sites, 29 (88%) achieved the national target of ≥80% for completeness and timeliness. Four DHOs failed to hit the target for both indicators: Machinga DHO, Karonga DHO, Balaka DHO, and Dowa DHO.

    Insights: While overall national reporting performance remains strong at 95%, persistent bottlenecks in Machinga, Karonga, Balaka, and Dowa DHOs prevent full national compliance.

    Recommendations: Zonal surveillance focal persons must work directly with Machinga, Karonga, Balaka, and Dowa DHOs to resolve data upload disruptions on OHSP.

    V. Targeted District & Programmatic Recommendations

    1. District Reporting Compliance

    Machinga, Karonga, Balaka, and Dowa DHOs must urgently address internal reporting bottlenecks to ensure weekly completeness and timeliness return to the ≥80% national benchmark on OHSP.

    2. Severe Malaria Management

    All District Health Offices must maintain rigorous triage and severe case protocols for malaria to address the 12 inpatient fatalities recorded in Week 41 and ensure uninterrupted supplies of mRDTs and parenteral Artesunate.

    3. Outbreak Surveillance & EPI Response

    DRRTs and EPI must accelerate rapid field investigations for verified community signals and conduct routine childhood immunization catch-up activities in active measles hotspot districts like Nsanje and Balaka.

    Official IDSR Documentation

    Access the full official PDF bulletin for Epidemiological Week 41, 2026, including detailed district-level performance tables and annexes.

    PUBLISHED BY

    Moses Nyambalo Phiri

    Ministry of Health, Lilongwe, Malawi

  • ISO 15189:2022 Accreditation.

    ISO 15189:2022 Accreditation.

    Malawi’s National Genomic Sequencing Reference Laboratory Achieves ISO 15189:2022 Accreditation | PHIM
    Laboratory Accreditation Milestone

    Malawi’s National Genomic Sequencing Reference Laboratory Achieves ISO 15189:2022 Accreditation

    Dr. Mirrium Nyenje Happy Abraham Manda |
    October 2026 6 min read Lilongwe
    SADCAS Assessors and PHIM Laboratory Staff during the ISO 15189:2022 Assessment
    ISO 15189:2022 Verified
    SADCAS assessors and PHIM laboratory officers following the successful initial assessment on 8–9 October 2026 in Lilongwe. Photo: Chris Kaudzu

    National Genomic Sequencing Reference Laboratory (NGSRL) at the Public Health Institute of Malawi (PHIM) has been recommended for accreditation to ISO 15189:2022, the gold standard for quality and competence in medical laboratories.

    The Southern African Development Community Accreditation Service (SADCAS) officially recommended the laboratory for accreditation following a rigorous initial on-site assessment conducted on 8–9 October 2026. The assessment concluded on a high note, with SADCAS assessors and PHIM leadership celebrating the culmination of years of dedicated work by the laboratory team to establish world-class genomic quality systems.

    International Recognition for National Data

    “Accreditation to ISO 15189:2022 is far more than a technical requirement. It is a strategic investment in the quality, credibility, and long-term sustainability of Malawi’s public health system—ensuring that our genomic data and disease surveillance results command global confidence.”

    What the NGSRL Does

    Operating under the Ministry of Health, PHIM plays a central role in strengthening Malawi’s public health laboratory system, epidemic intelligence, disease surveillance, and evidence-informed decision-making. As a specialized national facility, the NGSRL delivers crucial diagnostic and genomic surveillance services for priority pathogens, including:

    • Viral Threats: HIV, Influenza viruses, mpox virus, SARS-CoV-2, and epidemic-prone viral hemorrhagic fevers.
    • Bacterial & Parasitic Pathogens: Mycobacterium tuberculosis, Vibrio cholerae, and malaria parasites (Plasmodium falciparum).
    • Antimicrobial Resistance (AMR): Monitoring resistant superbugs and bacterial strain profiles nationwide.

    By generating molecular data for pathogen characterization, tracking transmission pathways, monitoring drug resistance, and investigating disease outbreaks, the NGSRL equips clinical managers and national public health programs with reliable, technically valid results.

    SADCAS Lead Assessor reviewing laboratory documentation and quality manuals
    Rigorous Document & Protocol Review SADCAS assessors evaluating NGSRL’s standard operating procedures, validation data, and quality management systems against ISO 15189:2022 standards.
    SADCAS Assessors and PHIM Scientists discussing technical genomics procedures
    Technical Competence Verification Assessors observing sequencing workflows, equipment calibration logs, and biosafety controls inside the NGSRL facility.

    A Capability Built Over Several Years

    In-country genomic sequencing is a transformative advancement for Malawi. Prior to establishing local sequencing infrastructure, specialized diagnostic samples had to be shipped to regional hubs in South Africa, Uganda, or Kenya—a process that often introduced logistical delays during health emergencies.

    Malawi’s journey gained momentum during the COVID-19 pandemic. Having detected the country’s first case in April 2020, national reference scientists deployed low-throughput equipment to sequence Malawi’s first batch of COVID-19 samples in June 2021, dramatically reducing reliance on external laboratories.

    Today, genomics is formally anchored in national policy. On 3 July 2025, the Ministry of Health launched the updated National Genomic Surveillance Implementation Plan (2025–2030), outlining a roadmap for integrating genomic technologies across public health facilities. SADCAS accreditation ensures this strategy rests on independently verified laboratory quality.

    Meeting the Updated ISO 15189:2022 Standard

    The timing of this achievement carries significance. Published on 6 December 2022, the updated ISO 15189:2022 edition replaced the earlier 2012 standard, placing greater emphasis on risk management, patient welfare, and continuous process control. SADCAS established a three-year transition window ending 5 December 2025. By achieving compliance, NGSRL operates under the latest, most stringent global standard.

    Why SADCAS Accreditation Matters

    As a multi-economy accreditation body recognized across SADC Member States, SADCAS operates under the Mutual Recognition Agreements (MRAs) of the International Laboratory Accreditation Cooperation (ILAC) and the African Accreditation Cooperation (AFRAC).

    This means sequencing results produced by Malawi’s NGSRL are internationally recognized. Whether reporting new viral variants, tracking regional drug resistance, or submitting epidemiological data to global repositories, accreditation guarantees that Malawi’s public health data meets uncompromising international quality benchmarks.

    Looking Ahead

    Accreditation is an ongoing commitment rather than a static destination. Moving forward, PHIM will continue to refine quality workflows, expand technical scopes, and invest in continuous professional development for laboratory staff—ensuring that Malawi remains at the forefront of disease surveillance and epidemic response.

    Share Article:

    Published By

    Moses Nyambalo Phiri

    Ministry of Health, Republic of Malawi